Search Results - "Burattini, Michela"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Gender Differences and Outcomes in Melanoma Patients by Morgese, Francesca, Sampaolesi, Caterina, Torniai, Mariangela, Conti, Alessandro, Ranallo, Nicoletta, Giacchetti, Alfredo, Serresi, Stefano, Onofri, Azzurra, Burattini, Michela, Ricotti, Giuseppe, Berardi, Rossana

    Published in Oncology and therapy (01-06-2020)
    “…Introduction Melanoma is one of the most common cancers in younger people. The incidence of cutaneous melanoma is increasing in patients of both sexes, with…”
    Get full text
    Journal Article
  2. 2

    Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology by Agostinelli, Veronica, Ballatore, Zelmira, Ricci, Giulia, Lucarelli, Alessandra, Burattini, Michela, Mariotti, Lorenzo, Catani, Claudia, Tarantino, Valentina, Berardi, Rossana

    “…Aim: Coronavirus disease 2019 (COVID-19) became pandemic on 11th March 2020 and it deeply stressed the healthcare system. Cancer patients represent a…”
    Get full text
    Journal Article
  3. 3

    A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic by Ballatore, Zelmira, Goudas, Amalia, Bozzi, Francesco, Lucarelli, Alessandra, Burattini, Michela, Ricci, Giulia, Savino, Francesco, Berardi, Rossana

    “…Aim: From the start of the pandemic, several aspects of healthcare policies changed, not least the clinical trials management from recruiting capabilities to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Abstract S07-03: Scientia potentia est: How the Italian world of oncology changes in the COVID19 pandemic by Ballatore, Zelmira, Bastianelli, Lucia, Merloni, Filippo, Ranallo, Nicoletta, Cantini, Luca, Mariotti, Lorenzo, Catani, Claudia, Burattini, Michela, Lucarelli, Alessandra, Berardi, Rossana

    Published in Clinical cancer research (15-09-2020)
    “…Background: After COVID-19 was declared a pandemic by the World Health Organization, a response from the Italian Health System to react to an unprecedented…”
    Get full text
    Journal Article
  6. 6

    Long-responders to anti-HER2 therapies: A case report and review of the literature by Cantini, Luca, Pistelli, Mirco, Savini, Agnese, Bastianelli, Lucia, Della Mora, Arianna, Merloni, Filippo, Burattini, Michela, Berardi, Rossana

    Published in Molecular and clinical oncology (01-01-2018)
    “…Since the introduction of targeted therapies, prognosis in human epidermal growth factor receptor (HER) 2-positive metastatic breast cancer (MBC) has radically…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Compliance with Breast and Cervical Cancer Screening Programs in Women: Results from a Population-Based Study by Berardi, Rossana, Nacciarriti, Dania, Tamburrano, Tiziana, Carbonari, Giovanna, Romagnoli, Emanuela, Duca, Monia, Burattini, Michela, Silva, Rosa Rita, Cellerino, Riccardo, Cascinu, Stefano

    Published in Tumori (01-09-2013)
    “…Aims and background Women's adherence to mammography and PAP test screening guidelines is a fundamental topic regarding women's health. The aim of the study…”
    Get full text
    Journal Article
  9. 9

    Compliance with breast and cervical cancer screening programs in women: results from a population-based study by Berardi, Rossana, Nacciarriti, Dania, Tamburrano, Tiziana, Carbonari, Giovanna, Romagnoli, Emanuela, Duca, Monia, Burattini, Michela, Silva, Rosa Rita, Cellerino, Riccardo, Cascinu, Stefano

    Published in Tumori (01-09-2013)
    “…AIMS AND BACKGROUNDWomen's adherence to mammography and PAP test screening guidelines is a fundamental topic regarding women's health. The aim of the study was…”
    Get full text
    Journal Article